Pro Share Advisors LLC Argenx Se Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

A detailed history of Pro Share Advisors LLC transactions in Argenx Se stock. As of the latest transaction made, Pro Share Advisors LLC holds 1,897 shares of ARGX stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,897

Previous 1,978 4.1%

Holding current value

$1.19 Million

Previous $850,000 20.94%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$434.22 - $551.9 $35,171 - $44,703	-81 Reduced 4.1%	1,897 $1.03 Million
Q2 2024 Aug 13, 2024	SELL	$356.01 - $451.55 $72,270 - $91,664	-203 Reduced 9.31%	1,978 $850,000
Q1 2024 May 08, 2024	BUY	$356.95 - $413.29 $46,046 - $53,314	129 Added 6.29%	2,181 $858,000
Q4 2023 Feb 14, 2024	BUY	$338.91 - $506.01 $35,924 - $53,637	106 Added 5.45%	2,052 $780,000
Q3 2023 Nov 13, 2023	BUY	$369.35 - $548.43 $5,170 - $7,678	14 Added 0.72%	1,946 $956,000
Q2 2023 Aug 10, 2023	SELL	$360.14 - $422.58 $44,297 - $51,977	-123 Reduced 5.99%	1,932 $752,000
Q1 2023 May 11, 2023	SELL	$334.23 - $403.65 $171,125 - $206,668	-512 Reduced 19.95%	2,055 $765,000
Q4 2022 Feb 02, 2023	BUY	$342.17 - $402.31 $2,737 - $3,218	8 Added 0.31%	2,567 $972,000
Q3 2022 Nov 04, 2022	BUY	$343.2 - $395.75 $84,084 - $96,958	245 Added 10.59%	2,559 $903,000
Q2 2022 Aug 01, 2022	SELL	$269.58 - $378.88 $146,112 - $205,352	-542 Reduced 18.98%	2,314 $877,000
Q1 2022 May 10, 2022	SELL	$254.45 - $351.06 $272,261 - $375,634	-1,070 Reduced 27.25%	2,856 $901,000
Q4 2021 Feb 08, 2022	SELL	$272.01 - $353.03 $548,100 - $711,355	-2,015 Reduced 33.92%	3,926 $1.38 Million
Q3 2021 Nov 12, 2021	BUY	$295.0 - $350.58 $295,885 - $351,631	1,003 Added 20.31%	5,941 $1.79 Million
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $394,663 - $491,077	1,535 Added 45.11%	4,938 $1.49 Million
Q1 2021 May 14, 2021	SELL	$268.3 - $380.31 $116,173 - $164,674	-433 Reduced 11.29%	3,403 $937,000
Q4 2020 Feb 09, 2021	SELL	$248.13 - $308.36 $104,462 - $129,819	-421 Reduced 9.89%	3,836 $1.13 Million
Q3 2020 Nov 13, 2020	BUY	$215.51 - $272.51 $124,564 - $157,510	578 Added 15.71%	4,257 $1.12 Million
Q2 2020 Aug 03, 2020	BUY	$127.44 - $232.72 $90,227 - $164,765	708 Added 23.83%	3,679 $829,000
Q1 2020 May 15, 2020	SELL	$108.83 - $165.23 $184,358 - $279,899	-1,694 Reduced 36.31%	2,971 $391,000
Q4 2019 Feb 12, 2020	SELL	$106.59 - $164.21 $120,659 - $185,885	-1,132 Reduced 19.53%	4,665 $749,000
Q3 2019 Nov 12, 2019	SELL	$113.31 - $150.51 $41,471 - $55,086	-366 Reduced 5.94%	5,797 $661,000
Q2 2019 Aug 13, 2019	SELL	$115.0 - $141.58 $105,110 - $129,404	-914 Reduced 12.92%	6,163 $873,000
Q1 2019 May 15, 2019	SELL	$98.85 - $134.59 $44,779 - $60,969	-453 Reduced 6.02%	7,077 $883,000
Q4 2018 Feb 14, 2019	BUY	$63.81 - $109.82 $480,489 - $826,944	7,530 New	7,530 $723,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Argenx Se Transaction History